Twitter | Search | |
Ana Vallejo
Periodista especializada en salud. Responsable de comunicación en . Perfil personal
800
Tweets
846
Following
910
Followers
Tweets
Ana Vallejo retweeted
Celia Marín Sep 23
Lecturas de domingo. Los insisten: “Si me lo receta un médico y lo compro en la farmacia, ¿cómo voy a pensar que es perjudicial?
Reply Retweet Like
Ana Vallejo retweeted
CML AdvocatesNetwork Sep 22
Our member organizations have started to celebrate See how commemorate 9/22: "We would like to express our heartfelt thanks to all the doctors for being the best and fighting side by side with the patient advocates "
Reply Retweet Like
Ana Vallejo Sep 20
Last day in the face to face meeting. starts talking about
Reply Retweet Like
Ana Vallejo retweeted
Matthew May Sep 19
Cohort 3, only one day to go! Saving the best for last with HTA?
Reply Retweet Like
Ana Vallejo retweeted
MPE Sep 19
More examples of activities in evidence-based advocacy at face to face meeting. This time the of Access to Treatment
Reply Retweet Like
Ana Vallejo retweeted
MPE Sep 19
Patients have a unique perspective on side effects. talks about the survey did some years ago about side effects in patients
Reply Retweet Like
Ana Vallejo retweeted
CML AdvocatesNetwork Sep 19
Our co-founder opening session about “Creating a plan for systematic community-led data collection” at
Reply Retweet Like
Ana Vallejo Sep 19
Time for community-led data collection
Reply Retweet Like
Ana Vallejo retweeted
Celia Marín Sep 19
Very interesting discussion at about leaflet’s information and the role of & organisations. My view: it is totally necessary to have full info and details. Reading is not mandatory but it is necessary for a good control of your disease management
Reply Retweet Like
Ana Vallejo Sep 18
Second day in the face to face meeting to talk about benefit-risk and ' organisations role in pharmacovigilance
Reply Retweet Like
Ana Vallejo retweeted
Matthew May Sep 7
What a week for two key guidances for published! Well done Ingrid Klingmann, Andrea Heckenberg and team for providing us with important Ethics guidance!
Reply Retweet Like
Ana Vallejo retweeted
MPE Aug 27
One of the challenges haematologists face in is how to treat frailer . Dr Zweegman explains this topic and other clinical challenges in this video: …/clinical-challenges-in-myeloma-2/
Reply Retweet Like
Ana Vallejo Aug 24
Ryanair cobrará por las maletas de mano a partir de noviembre via
Reply Retweet Like
Ana Vallejo retweeted
MPE Aug 24
is a process that can help determine whether a medicine or other health technology should be made available in a health system. Find in this Q&A more information about this process and how patient organisations can influence decision-making.
Reply Retweet Like
Ana Vallejo retweeted
MPE Aug 20
A new scale for tumour DNA mutations which will simplify and standardise choices for targeted has been agreed by leading cancer specialists in Europe and North America, according to the announcement the has done today.
Reply Retweet Like
Ana Vallejo Aug 15
Mucho queda por hacer aún para que las personas con discapacidad física puedan disfrutar de algo tan normal como ir a la playa. Una pena
Reply Retweet Like
Ana Vallejo retweeted
MPE Jul 23
MPE has interviewed Dr Michael Hudecek, coordinator of on SLAMF7 therapy in and the Phase I/II . Big thanks to for help filming!
Reply Retweet Like
Ana Vallejo retweeted
WECAN Jul 22
The contribution of patients and patient experts provides tangible value to stakeholders and society. Should this work be fairly compensated? Patient advocates, please respond to the survey on Fair Market Value:
Reply Retweet Like
Ana Vallejo Jul 8
Puedes descargar la guía o solicitar un ejemplar en este enlace: te dará más información sobre cómo solicitarlo
Reply Retweet Like
Ana Vallejo Jul 4
Muy buena pinta la del manual para pacientes y familiares "¿Cómo convivir con el ?" de que acabo de recibir. Muchos aún no se hacen a la idea de la importancia de libros como éste. Mil gracias!
Reply Retweet Like